ArticleInternational journal of general medicine2025
The Effects of HFOV-VG vs HFOV on Bronchopulmonary Dysplasia and Neurobehavioral Development in Preterm Infants with Perinatal Acute Respiratory Distress Syndrome.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to explore whether high-frequency oscillatory ventilation with volume-guarantee (HFOV-VG) strategy could reduce the incidence of bronchopulmonary dysplasia (BPD) and improve poor neurological prognosis in premature infants with perinatal acute respiratory distress syndrome (NARDS) compared with high-frequency oscillatory ventilation (HFOV) alone. Methods: This retrospective single-center study conducted in the neonatal intensive care unit (NICU) from January 2016 and December 2023. One hundred and seventy-two premature infants (32 weeks ≤ gestational age < 37 weeks) with NARDS were enrolled. Infants were categorized into two groups based on ventilation strategy: HFOV-VG (n = 70) and HFOV (n = 102). The demographic data, perinatal factors, primary and secondary outcomes were compared. Univariate and multivariate logistic regression analyses were performed to assess the association between the ventilation strategy and primary outcomes. Results: The invasive mechanical ventilation duration and incidence of BPD in HFOV-VG group were lower than those in HFOV group. There were no significant differences in complication, and the scores of neurobehavioral development between the two groups of children who were followed up until correct age of 6 months. The multivariate logistic regression analysis identified that the ventilation strategy of HFOV-VG was an independent protective factor of BPD. However, HFOV-VG was not associated with a statistically significant improvement in short-term neurodevelopmental outcomes. Subgroup analysis showed that there were no significant interactions in any of the subgroups except for birth weight subgroup. The association between HFOV-VG mode and the incidence of BPD was more pronounced in neonates with birth weight < 2500g. Conclusion: The ventilation strategy of HFOV-VG was a promising lung protective mode for premature infants with perinatal ARDS, which can shorten mechanical ventilation duration and may reduce the incidence of BPD. However, it did not seem to be superior to HFOV in improving short-term neurodevelopmental outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.